MeSH term
Frequency | Condition_Probility | Child, Preschool | 6 | 0.0 |
Humans | 78 | 0.0 |
Chromosome Mapping | 10 | 0.0 |
*Gene Expression | 2 | 0.0 |
Gene Library | 2 | 0.0 |
*Genes | 3 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 35 | 0.0 |
Adult | 25 | 0.0 |
Collagen/genetics | 6 | 6.0 |
Gene Expression Profiling | 3 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 49 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Animals | 18 | 0.0 |
Biomechanics | 2 | 1.0 |
Female | 40 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Rats | 2 | 0.0 |
Cross-Sectional Studies | 2 | 0.0 |
Male | 35 | 0.0 |
Middle Aged | 17 | 0.0 |
Base Sequence | 20 | 0.0 |
Cells, Cultured | 11 | 0.0 |
DNA Mutational Analysis | 6 | 0.0 |
Fibroblasts | 2 | 0.0 |
Molecular Sequence Data | 22 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Phenotype | 14 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Fibrosis | 3 | 2.0 |
Mice | 11 | 0.0 |
Transfection | 2 | 0.0 |
Gene Frequency | 5 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Collagen/*genetics | 27 | 5.0 |
*Multigene Family | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Skin/cytology/*metabolism | 2 | 5.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Procollagen/genetics/metabolism | 2 | 40.0 |
Aspartic Acid/genetics | 2 | 3.0 |
Ehlers-Danlos Syndrome/complications/*genetics | 2 | 66.0 |
Glycine/genetics | 3 | 3.0 |
*Point Mutation | 5 | 0.0 |
Adolescent | 11 | 0.0 |
Aged | 11 | 0.0 |
Child | 5 | 0.0 |
Comparative Study | 8 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Infant | 2 | 0.0 |
Mutation | 6 | 0.0 |
Pregnancy | 3 | 0.0 |
Fibroblasts/metabolism | 5 | 0.0 |
Linkage (Genetics) | 4 | 0.0 |
Collagen Type III/*genetics | 3 | 60.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Chromosome Banding | 3 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Genetic Markers | 4 | 0.0 |
Collagen/*genetics/metabolism | 3 | 8.0 |
Collagen/chemistry/*genetics | 3 | 10.0 |
Ehlers-Danlos Syndrome/*genetics/metabolism | 2 | 66.0 |
Polymerase Chain Reaction | 13 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Skin/pathology | 2 | 0.0 |
Ehlers-Danlos Syndrome/*genetics | 16 | 53.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Exons | 4 | 0.0 |
*Mutation | 8 | 0.0 |
Skin/ultrastructure | 2 | 9.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
Pedigree | 20 | 0.0 |
Syndrome | 2 | 0.0 |
Alleles | 10 | 0.0 |
Introns | 3 | 0.0 |
Oligonucleotide Probes/genetics | 4 | 3.0 |
Polymorphism, Genetic | 6 | 0.0 |
*Repetitive Sequences, Nucleic Acid | 4 | 1.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Blotting, Southern | 2 | 0.0 |
*Chromosome Mapping | 5 | 0.0 |
Hamsters | 3 | 0.0 |
Hybrid Cells | 3 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Sheep/*genetics | 3 | 5.0 |
DNA/genetics | 7 | 0.0 |
*Exons | 2 | 0.0 |
Procollagen/genetics | 4 | 16.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Cyclic AMP/analysis | 2 | 8.0 |
Hypertrophy | 2 | 1.0 |
Mice, Transgenic | 4 | 0.0 |
Collagen/biosynthesis/*genetics | 2 | 6.0 |
English Abstract | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Nucleic Acid Hybridization | 6 | 0.0 |
*Chromosomes, Human, Pair 2 | 7 | 2.0 |
DNA | 3 | 0.0 |
DNA Probes | 3 | 0.0 |
Fibronectins/genetics | 2 | 6.0 |
Species Specificity | 3 | 0.0 |
Glutamic Acid | 3 | 3.0 |
Collagen/analysis/*genetics | 2 | 16.0 |
Restriction Mapping | 5 | 0.0 |
Aneurysm, Dissecting/*genetics | 2 | 100.0 |
Glycine/*genetics | 2 | 5.0 |
Ehlers-Danlos Syndrome/diagnosis/*genetics | 2 | 100.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Procollagen/*genetics | 7 | 6.0 |
*RNA Splicing | 2 | 0.0 |
Temperature | 2 | 0.0 |
Mutation/genetics | 4 | 0.0 |
Joint Instability/*genetics | 2 | 66.0 |
Lod Score | 3 | 0.0 |
Genes, Structural | 3 | 0.0 |
*Genetic Markers | 3 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Peptide Mapping | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 3 | 0.0 |
*Genes, Structural | 6 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Marfan Syndrome/*genetics | 3 | 5.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
*Genes, Dominant | 2 | 0.0 |
Collagen Type III/genetics | 2 | 40.0 |
*Chromosomes, Human, 1-3 | 2 | 3.0 |
Cricetulus | 2 | 0.0 |
DNA Restriction Enzymes | 2 | 0.0 |
